IT1263143BITMI930181AITMI930181AIT1263143BIT 1263143 BIT1263143 BIT 1263143BIT MI930181 AITMI930181 AIT MI930181AIT MI930181 AITMI930181 AIT MI930181AIT 1263143 BIT1263143 BIT 1263143B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpafiledCriticalZambon Spa
Priority to ITMI930181ApriorityCriticalpatent/IT1263143B/it
Publication of ITMI930181A0publicationCriticalpatent/ITMI930181A0/it
Publication of ITMI930181A1publicationCriticalpatent/ITMI930181A1/it
Application grantedgrantedCritical
Publication of IT1263143BpublicationCriticalpatent/IT1263143B/it
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Vengono descritti la preparazione di una composizione farmaceutica contenente N-acetil-cisteina come principio attivo ed il suo uso nella prevenzione dei danni genotossici indotti dal benzene.
Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene
Legal Events
Date
Code
Title
Description
0001
Granted
TA
Fee payment date (situation as of event date), data collected since 19931001